Overview
ALC market data
Price History
ALC price chart
Valuation & Profitability
- P/E (TTM)
- 41.09 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.98 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.11 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 51.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $47.80 – $74.34 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $27.4K · P/B 1.76 · P/S 3.17.
Company news
Mizuho Maintains Outperform on Alcon, Lowers Price Target to $80Benzinga · Jul 15, 2026, 6:21 PM
Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 OthersGlobenewswire Inc · Jul 13, 2026, 12:45 PM
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · Jul 8, 2026, 10:15 PM
Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular LensesBenzinga · Jul 6, 2026, 8:20 PM